期刊文献+

银杏叶提取物对颅内血管疾病手术患者超氧化物歧化酶及丙二醛的影响 被引量:1

Effects of Ginkgo biloba extract on SOD and MDA in intracranial vascular diseases operation
暂未订购
导出
摘要 目的通过观察银杏叶提取物预处理前后患者超氧化物歧化酶(SOD)、丙二醛(MDA)等指标的变化,探讨银杏叶提取物在颅内血管手术围术期脑保护的作用。方法择期行颅内血管手术成年患者40例,分为银杏叶治疗组(Y组)和对照组(D组),每组20例。两组均采用静吸复合全麻。麻醉诱导后,Y组经静脉滴注银杏叶提取物注射液1mg/kg(用生理盐水250mL稀释),30min滴完;D组同速度输入等量生理盐水。分别于手术前(T0)、手术1h(T1)、手术2h(T2)、手术6h(T3)、手术后12h(T4)抽取颈静脉球部血测SOD、MDA。记录两组患者手术后12h(T4)GCS评分以及术后恢复情况。结果 Y组T2、T3的SOD较T0升高,T2、T3的MDA较T0降低,但差异无统计学意义(P>0.05)。D组T2、T3、T4的SOD较T0降低,T2、T3、T4的MDA较T0升高明显(P<0.05)。组间比较,T2、T3、T4的SOD较D组明显升高(P<0.01),Y组T2、T3、T4的MDA较D组明显降低(P<0.01)。两组T4的GCS评分比较差异无统计学意义(P>0.05)。结论在颅内血管疾病手术中给予银杏叶提取物预处理具有脑保护的作用,且围术期并发症少,手术预后良好。 Objective To investigate the perioperative cerebral protective effects of Ginkgo biloba extract for intracranial vascular operation on SOD and MDA. Methods Forty patients scheduled for elective intracranial vascular operation under general anesthesia were enrolled and randomly allocated into two groups (n = 20) , Group Y and Group D. After the induction of anesthesia, intravenous injection of Ginkgo biloba extract (1 mg/kg) and placebo saline were given to the participants in Group Y and D, respectively. The SOD and MDA from jugular bulb blood before operation (T0) , and at the 1st (T1), the 2nd (T2), the 6th hour of operation (T3), and 12 hours after operation (T4). The GCS was recorded at T4. Results Minor increase of SOD and reduction of MDA in Group Y at T2 and T3 were revealed (P 〉 0.05 ). However, significant reduction in SOD and elevation of MDA were revealed in Group D at T2, T3, and T4 ( P 〈 0.05 ). There was also significant differences in SOD and MDA between the 2 groups at T2, T3, and T4 (P 〈0. 01 ). No significant difference in GCS between the two groups was recorded ( P 〉 0. 05 ). Conclusion Ginkgo biloba extract provides neuroprotective effects in intracranial vascular disease operation.
出处 《广东医学》 CAS CSCD 北大核心 2013年第7期1047-1049,共3页 Guangdong Medical Journal
基金 广州市中医药科技项目(编号:20112233010003)
关键词 银杏叶提取物 颅内血管疾病手术 超氧化物歧化酶 丙二醛 extract of Ginkgo biloba intracranial vascular disease operation SOD MDA
  • 相关文献

参考文献9

  • 1SMITH P F, MACLENNAN K, DARLINGTON C L. The neuro- protective properties of the Ginkgo biloba leaf: a review of the pos- sible relationship to platelet - activating factor (PAF) [ J ]. Ethno- pharmacol, 1996, 50(3) : 131 - 139.
  • 2吴琪,张鑫,杭春华,张庆荣.不同治疗方式和时机对颅内破裂动脉瘤患者短期疗效的影响[J].中国脑血管病杂志,2009,6(5):233-238. 被引量:5
  • 3黄茸茸,明亮,曹曦,李静,李维祖,李卫平.黄芪提取物对大鼠局灶性脑缺血再灌注损伤炎症反应的影响[J].安徽医科大学学报,2005,40(6):508-511. 被引量:14
  • 4NI Y C, ZHAO B L, HOU J W, et al. Protection of cerebellar neuron by ginkgo biloba extract against apoptosis induced by hy- droxyl radials[J]. Neurosci Lett, 1996, 214(2/3) : 115 -118.
  • 5YANAISANA M, KURIHARA H, KIMURA S, et al. A novel po- tent vasoconstrictor peptide prodded by vascular endothelial cell [J]. Nature, 1988, 322(6163):411-415.
  • 6KRESSMANN S, MULLER W E, BLUME H H, et al. Pharma- ceutical quality of different Ginkgo biloba brands [ J ]. J Pharm Pharmacol, 2002, 54(5): 661 -669.
  • 7OYAMA Y, CHILDAHISA L, TOSHIKO U, et al. Ginkge biloba extract protects bran neurons against taxidatinve sorees induced by bydrogen peroxide[J]. Brain Res, 1996, 712(2) : 349 -352.
  • 8HIEDA H S, GOMEZ SANCHEZ C E. Hypoxia increases endo- thelin release in bovine endothelial cellsin calture, but epineph- rine, nompinephrine, serotonin, histamine and angiotensin do not [J]. LifeSei, 1999, 47(3): 247 -251.
  • 9CALAPAI G, CRUPI A, FIRENZUOLI F, et al. Neuroprotective effects of Ginkgo biloba extract in brain isehemia are mediated by inhibition of nitric oxide synthesis [ J ]. Life Sci, 2000, 67 (22) : 2673 - 2683.

二级参考文献20

  • 1闵小芬,李卫平,王绍斌,何婷,尹艳艳,明亮.黄芪提取物对局灶性脑缺血再灌注损伤的抗氧化及线粒体保护作用[J].中国药理学通报,2005,21(2):216-219. 被引量:41
  • 2赵刚,尹方明,李林,王伟民,粱军潮,贺道华,王伟中.血管内栓塞治疗颅内动脉瘤的疗效[J].中华神经医学杂志,2005,4(9):935-937. 被引量:1
  • 3毛颖,周良辅.急性自发性蛛网膜下腔出血的规范化治疗[J].中国临床神经科学,2007,15(3):302-305. 被引量:14
  • 4包仕尧,傅琦,张志琳,刘春风.白细胞在实验性脑缺血中作用及中药川芎嗪和丹皮酚对其影响的研究[J].中国神经精神疾病杂志,1997,23(1):7-10. 被引量:33
  • 5Lafuente J,Maurice-Williams RS.Ruptured intracranial aneurysms:the outcome of surgical treatment in experienced hands in the period prior to the advent of endovascular coiling[J].J Neurol Neurosurg Psychiatry,2003,74(12):1680-1684.
  • 6Molyneux AJ,Kerr RS,Yu LM,et al.International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms:a randomised comparison of effects on survival,dependency,seizures,rebleeding,subgroups,and aneurysm occlusion[J].Lancet,2005,366(9488):809-817.
  • 7Park HK,Horowitz M,Jungreis C,et al.Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms[J].AJNR Am J Neuro-radiol,2005,26(3):506-514.
  • 8Linfante I,Wakhloo AK.Brain aneurysms and arteriovenous malformations:advancements and emerging treatments in endovascular embolization[J].Stroke,2007,38(4):1411-1417.
  • 9Ross N,Hutchinson PJ,Seeley H,et al.Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage:report of a prospective study[J].J Neurol Neurosurg Psychiatry,2002,72(4):480-484.
  • 10Natarajan SK,Sekhar LN,Ghodke B,et al.Outcomes of ruptured intracranial aneurysms treated by microsurgical clipping and endovascular coiling in a high-volume center[J].AJNR Am J Neuroradiol,2008,29(4):753-759.

共引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部